stopOverflowHandler
HILDA LIF ANTIBODIES
Principal Investigator: JL. TAUPIN
TECHNICAL DESCRIPTION

Different hybrid cell lines, and notably those designated 1F10 and 7D2, (hereinafter referred to as the "hybridomes"), which produce the monoclonal antibodies anti-Human Interleukin for DA Cells/Leukemia Inhibitory Factor (HILDA/LIF) were obtained during the course of a research in the laboratory. In particular, the study and selection of the monoclonal antibodies and the development of an ELISA test were realized in the Laboratory.


¡Para continuar la lectura conéctese ! au lieu de ¡Para leer la consecuencia, conectarse!
 
< Anterior   Siguiente >
 
 

indentificación






Direct Access
+33 1 40 51 00 90
17/01/13 : Science to Market, Cologne, Germany 5th - 6th March, 2013

Science to Market - S2M - is the platform for European scientific research and biopharmaceutical industry ...
Details ...



17/01/13 : CNRS INNOVATION la lettre n°1  La première édition de CNRS INNOVATION la lettre est parue le 11 Janvier 2013 Lien Details ...



04/02/13 : Une technologie valorisée par FIST SA dans la presse (Muller)  Lupus : des essais cliniques confirment l'efficacité du peptide P140/LupuzorTM Details ...



 
   
viagra 100mg